AXQ Capital LP
Investment Details
Investor Type
Hedge Fund
Asset Class Focus
Equity, Derivatives
Stage Focus
Growth, Late Stage, Pre-IPO
Geographical Focus
United States, United Kingdom, Canada, Germany, Hong Kong, Japan, Australia, Singapore, China, India, Brazil, France, Italy, Switzerland, Spain, Mexico, South Korea, Netherlands, South Africa, Russia
Industries Focus
- Financial Services
- Technology
- Healthcare
- Energy
- Consumer Goods
- Industrials
- Real Estate
- Materials
- Telecommunications
- Utilities
- Consumer Services
- Basic Materials
- Consumer Non-Durables
- Financials
- Technology Hardware & Equipment
Investment Size:
1,000,000 to 50,000,000 USD
Investor Details Founded: 2021
AXQ Capital LP is a quantitative investment firm specializing in systematic, market-neutral equity strategies. The firm employs proprietary quantitative models to generate consistent alpha across global markets, focusing on publicly traded securities and exchange-listed derivatives. Their investment approach emphasizes active trading with high portfolio turnover, utilizing technical analysis to capture mean-reversion and momentum opportunities.
Founded in August 2021, AXQ Capital LP is headquartered in Wilmington, Delaware, with offices in Jersey City, New Jersey, and New York City. The firm manages approximately $287 million in regulatory assets under management as of December 31, 2024. AXQ Capital LP serves institutional and accredited investors, offering investment sub-advisory services to private pooled investment vehicles.
The firm's investment strategy is designed to maximize risk-adjusted returns through a market-neutral equity investment program. This strategy involves active trading of publicly traded securities and exchange-listed derivatives, with a focus on technical analysis to identify mean-reversion and momentum opportunities. AXQ Capital LP emphasizes robust risk control frameworks to minimize operational errors and does not participate in wrap fee programs. Investors are exposed to risks including leverage, short sales, and exchange-traded products, but benefit from the firm's advanced risk management and compliance procedures.
Requirements
- Institutional investors
- Accredited investors
Contact
[Official Website Hidden]
[HQ Location Hidden]
[Email Hidden]
[Contact Number Hidden]
Portfolio Companies
- Exelixis
- Neurocrine Biosciences
- Thermo Fisher Scientific
- Carnival Corp.
- Godaddy Inc.
Claim this Investor
Are you an official representative of AXQ Capital LP?
Claim this investor to update information, manage your profile, and get a verified seal.
Claim